Now, it must be noted that Palantir is trading at a price to earnings (P/E) ratio of 248 right now which is very high.

The company is pursuing a Phase 3 trial in its most exciting pipeline drug, and investors are awaiting potentially exciting data by the end of September.

You've tucked away $1 million for retirement and understand that you'll have to begin taking required minimum distributions ...

Costco's fourth-quarter earnings report took the stock to around $1,000 per share, but can it continue rising?

Since October 2025, the crypto market has gone through a major downturn, losing nearly $2 trillion in value. The silver ...

Pershing Square Capital Management's billionaire boss sent Chipotle packing in favor of a truly "magnificent" and historically inexpensive stock.

Zcash was built to be a better version of Bitcoin. It's still minuscule in comparison. But there are a few reasons to believe it might be more valuable than Bitcoin anyway one day. Zcash and Bitcoin ...

While both of these software leaders' stocks have been beaten down, one company has much better growth prospects than the ...

Bitcoin, Ethereum, and XRP have all lost a lot of their value recently. They might lose even more. These aren't good reasons to sell those assets. When your investments are down a lot with no end in ...

As the first artificial intelligence (AI) payment blockchain, Kite offers investors exposure to AI and blockchain technology. If AI agents take off as expected, they could lead to soaring demand for ...

These two healthcare leaders have businesses built to withstand economic downturns. Both have grown their dividends at a pretty good clip over the past decade. CVS Health is a leading pharmacy chain ...

While the chipmaker's staggering top-line growth captures the headlines, another important aspect of the bull case for the ...